ClinicalTrials.Veeva

Menu

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

Yale University logo

Yale University

Status and phase

Completed
Phase 4

Conditions

Binge Eating
Obesity

Treatments

Drug: Xenical + behavioral intervention
Behavioral: Behavioral intervention + placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00516919
0608001753

Details and patient eligibility

About

This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.

Enrollment

79 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Monolingual Spanish Speaking
  • Obese (BMI >= 30)

Exclusion criteria

  • Pregnancy
  • Current cardiac disease
  • Serious neurologic illnesses

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

79 participants in 2 patient groups

1
Experimental group
Description:
Xenical + behavioral intervention
Treatment:
Drug: Xenical + behavioral intervention
2
Active Comparator group
Description:
Placebo + behavioral intervention
Treatment:
Behavioral: Behavioral intervention + placebo

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems